Journal
JCI INSIGHT
Volume 7, Issue 12, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.155928
Keywords
-
Categories
Funding
- NIH National Eye Institute (NEI) [EY11254]
- Lowy Medical Research Institute
- F30 Ruth L. Kirschstein National Research Service Award from the NEI [EY029141-01]
- University of California, San Diego [GM007198-40]
- [S10 OD023555]
Ask authors/readers for more resources
The study found that bioactive extracellular vesicles from endothelial colony-forming cells (ECFCs) with high expression of CD44 have neurovasculotrophic effects, and may repair dysfunction of the neurovascular unit (NVU) through multiple mechanisms.
Disruption of the neurovascular unit (NVU) underlies the pathophysiology of various CNS diseases. One strategy to repair NVU dysfunction uses stem/progenitor cells to provide trophic support to the NVU's functionally coupled and interdependent vasculature and surrounding CNS parenchyma. A subset of endothelial progenitor cells, endothelial colony-forming cells (ECFCs) with high expression of the CD44 hyaluronan receptor (CD44(h)(i)), provides such neurovasculotrophic support via a paracrine mechanism. Here, we report that bioactive extracellular vesicles from CD44(h)(i) ECFCs (EVs(hi)) are paracrine mediators, recapitulating the effects of intact cell therapy in murine models of ischemic/neurodegenerative retinopathy; vesicles from ECFCs with low expression levels of CD44 (EVs(lo)) were ineffective. Small RNA sequencing comparing the microRNA cargo from EVs(hi) and EVs(lo) identified candidate microRNAs that contribute to these effects. EVs(hi) may be used to repair NVU dysfunction through multiple mechanisms to stabilize hypoxic vasculature, promote vascular growth, and support neural cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available